Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
3.
Obstet Med ; 13(1): 30-36, 2020 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-32284730

RESUMO

AIM: To assess the glycaemic profile and glycaemic variation in the second and third trimesters of normal pregnancies. METHODOLOGY: Healthy pregnant women aged 19-35 years between 24 and 36 weeks of gestation were recruited for ambulatory glucose profile monitoring. A total of 18 women in the second trimester, 15 women in the third trimester and 9 healthy non-pregnant women were recruited providing, respectively, 205 days (19,680 data points), 147 days (14,112 data points) and 100 days (9,600 data points) for analysis. RESULTS: Mean blood glucose level was 20.2% lower in the second trimester and 10.6% lower in the third trimester than non-pregnant women (p < 0.001). In pregnancy, it took 15 to 20 minutes more to reach peak postprandial blood glucose levels compared to non-pregnant women (p = 0.003). Glycaemic variability was more in the third trimester (p < 0.001). CONCLUSION: There is tight blood sugar control along with lower mean blood glucose in healthy pregnant women compared to non-pregnant women. Despite this tight glycaemic control, glycaemic variability is higher during pregnancy.

4.
BJOG ; 126 Suppl 4: 27-33, 2019 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-31257712

RESUMO

OBJECTIVE: To compare glycaemic profiles in women with mild gestational diabetes (GDM) and those with a healthy pregnancy. DESIGN: Observational study. SETTING: Hospital-based. POPULATION: Healthy nonpregnant, healthy pregnant, and women with GDM, diagnosed by oral glucose tolerance test. METHODS: Nine nonpregnant women, 33 healthy pregnant women, 29 pregnant women with GDM between 24 and 36 weeks' gestation, received ambulatory glucose profile (AGP) monitoring for a 2-week period. AGP values were compared in the three groups: 100 days (9600 data points) for nonpregnant women, 396 days (33 792 data points) for healthy pregnant women, and 348 days (34 408 data points) for women with GDM. RESULTS: Mean glucose values for fasting and postmeals were highest in nonpregnant healthy women and lowest in healthy pregnant women (P < 0.001). Women with mild GDM had significantly higher blood glucose values than did healthy pregnant women, though still within the target range. Blood glucose values >160 mg/dl were observed in 41.4% (12/29) in the GDM group compared with 18.2% in women with a healthy pregnancy. The maximum peak of day and night time glucose was respectively 234 and 215 mg/dl in women with GDM compared with 183 and 171 mg/dL in the control group. Glycaemic variability as measured by interquartile range was higher in GDM pregnancies. CONCLUSIONS: Although the blood glucose level remained within the target levels in women with mild GDM, glycaemic variability and mean blood glucose levels were significantly higher among women with GDM than among women with a healthy pregnancy. TWEETABLE ABSTRACT: Average blood glucose levels and glycaemic variability are significantly higher in women with GDM than in women with a healthy pregnancy.


Assuntos
Automonitorização da Glicemia/métodos , Glicemia/metabolismo , Diabetes Gestacional/sangue , Índice Glicêmico , Adulto , Estudos de Casos e Controles , Feminino , Idade Gestacional , Humanos , Projetos Piloto , Gravidez , Adulto Jovem
5.
J Assoc Physicians India ; 64(7 Suppl): 3-11, 2016 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-28805048

RESUMO

Influenza is a global public health problem and concern especially in high risk people. Prevention plays a key role in avoiding complications of influenza related illnesses. Despite the existing prevalence of influenza, and documented importance of vaccination, the uptake of influenza vaccine is very poor. This document provide recommendations for influenza vaccination in high-risk individuals and help implement best practices in the South Asian region and improve coverage of influenza vaccination to achieve better outcomes in this population.


Assuntos
Vacinas contra Influenza/uso terapêutico , Influenza Humana/prevenção & controle , Adulto , Ásia/epidemiologia , Humanos , Influenza Humana/epidemiologia , Guias de Prática Clínica como Assunto , Medição de Risco , Estações do Ano
6.
J Assoc Physicians India ; 57: 163-70, 2009 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19582986

RESUMO

Asian Indians exhibit unique features of obesity; excess body fat, abdominal adiposity, increased subcutaneous and intra-abdominal fat, and deposition of fat in ectopic sites (liver, muscle, etc.). Obesity is a major driver for the widely prevalent metabolic syndrome and type 2 diabetes mellitus (T2DM) in Asian Indians in India and those residing in other countries. Based on percentage body fat and morbidity data, limits of normal BMI are narrower and lower in Asian Indians than in white Caucasians. In this consensus statement, we present revised guidelines for diagnosis of obesity, abdominal obesity, the metabolic syndrome, physical activity, and drug therapy and bariatric surgery for obesity in Asian Indians after consultations with experts from various regions of India belonging to the following medical disciplines; internal medicine, metabolic diseases, endocrinology, nutrition, cardiology, exercise physiology, sports medicine and bariatric surgery, and representing reputed medical institutions, hospitals, government funded research institutions, and policy making bodies. It is estimated that by application of these guidelines, additional 10-15% of Indian population would be labeled as overweight/obese and would require appropriate management. Application of these guidelines on countrywide basis is also likely to have a deceleration effect on the escalating problem of T2DM and cardiovascular disease. These guidelines could be revised in future as appropriate, after another large and countrywide consensus process. Till that time, these should be used by clinicians, researchers and policymakers dealing with obesity and related diseases.


Assuntos
Povo Asiático , Síndrome Metabólica/diagnóstico , Síndrome Metabólica/terapia , Obesidade/diagnóstico , Obesidade/terapia , Gordura Abdominal , Exercício Físico , Humanos , Índia , Síndrome Metabólica/etnologia , Obesidade/etnologia , Guias de Prática Clínica como Assunto
8.
Indian Heart J ; 60(2): 161-75, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-19218731

RESUMO

UNLABELLED: Asian Indians--living both in India and abroad--have one of the highest rates of coronary artery disease (CAD) in the world, three times higher than the rates among Caucasians in the United States. The CAD among Indians is usually more aggressive at the time of presentation compared with whites or East Asians. The overall impact is much greater because the CAD in Asian Indians affects the "younger" working population. This kind of disproportionate epidemic among the young Indians is causing tremendous number of work days lost at a time when India is experiencing a dizzying economic boom and needs a healthy populace to sustain this boom. While the mortality and morbidity from CAD has been falling in the western world, it has been climbing to epidemic proportions among the Indian population. Various factors that are thought to contribute to this rising epidemic include urbanization of rural areas, large-scale migration of rural population to urban areas, increase in sedentary lifestyle, abdominal obesity, metabolic syndrome, diabetes, inadequate consumption of fruits and vegetables, increased use of fried, processed and fast foods, tobacco abuse, poor awareness and control of CAD risk factors, unique dyslipidemia (high triglycerides, low HDL-cholesterol levels), and possible genetic predisposition due to lipoprotein (a) [Lp(a)] excess. The effect of established, as well as novel, risk factors is multiplicative, not just additive (total effect>sum of parts). The management would require aggressive individual, societal, and governmental (policy and regulatory) interventions. Indians will require specific lower cut-offs and stricter goals for treatment of various risk factors than is currently recommended for western populations. To this end, the First Indo-US Healthcare Summit was held in New Delhi, India on December 14 and 15, 2007. The participants included representatives from several professional entities including the American Association of Physicians of Indian origin (AAPI), Indian Medical Association (IMA), Medical Council of India (MCI), and Government of India (GOI) with their main objective to address specific issues and provide precise recommendations to implement the prevention of CAD among Indians. The summary of the deliberations by the committee on "CAD among Asian Indians" and the recommendations are presented in this document. OBJECTIVES: Discussion of demographics of CAD in Indians-both in India and abroad, current treatment strategies, primordial, primary, and secondary prevention. Development of specific recommendations for screening, evaluation and management for the prevention of CAD disease epidemic among Asian Indians. Recommendations for improving quality of care through professional, public and private initiatives.


Assuntos
Doença da Artéria Coronariana/prevenção & controle , Prevenção Primária/métodos , Anticolesterolemiantes/uso terapêutico , Anti-Hipertensivos , Doença da Artéria Coronariana/tratamento farmacológico , Doença da Artéria Coronariana/epidemiologia , Doença da Artéria Coronariana/cirurgia , Humanos , Índia/epidemiologia , Estilo de Vida , Programas de Rastreamento , Atividade Motora , Guias de Prática Clínica como Assunto/normas , Fatores de Risco
10.
J Indian Med Assoc ; 92(1): 31-2, 1994 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-8207280

RESUMO

PIP: HIV can be transmitted in the health care setting from patient to patient, from patient to health care worker, and from health care worker to patient. The risk of transmission in each of these pathways depends upon the number of infected individuals in the population, the frequency of exposure to contaminated medical instruments, the relative infectivity of the virus, and the concentration of virus in the blood. This paper, however, concentrates upon the potential risk of being infected with HIV borne by health care providers exposed to blood and other body fluids. While some fear of infection may be justified among such health professionals, lack of knowledge about the magnitude of risk, the epidemic nature of the disease, the high mortality rate, the lack of effective treatment, and the social stigma attached to HIV/AIDS can also simply amplify the perceived risk. The author discusses risk assessment, universal precautions, post-exposure prophylaxis, the risk to patients, burn out among health care professionals, strategies for preventing burn out, and individual and organizational interventions.^ieng


Assuntos
Países em Desenvolvimento , Infecções por HIV/transmissão , Transmissão de Doença Infecciosa do Paciente para o Profissional , Transmissão de Doença Infecciosa do Profissional para o Paciente , Doenças Profissionais/etiologia , Infecções por HIV/prevenção & controle , Humanos , Índia , Doenças Profissionais/prevenção & controle , Fatores de Risco
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA